CalciMedica Inc. (NASDAQ: CALC)
$2.7700
+0.0100 ( -1.42% ) 68.6K
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Market Data
Open
$2.7700
Previous close
$2.7600
Volume
68.6K
Market cap
$37.21M
Day range
$2.7500 - $2.8550
52 week range
$2.0500 - $8.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 01, 2024 |
4 | Insider transactions | 1 | Nov 01, 2024 |
8-k | 8K-related | 18 | Oct 31, 2024 |
8-k | 8K-related | 54 | Oct 30, 2024 |
8-k | 8K-related | 15 | Oct 30, 2024 |
4 | Insider transactions | 1 | Sep 11, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |